The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fuxa, M.
Right arrow Articles by Busslinger, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fuxa, M.
Right arrow Articles by Busslinger, M.
The Journal of Immunology, 2007, 178: 3031-3037.
Copyright © 2007 by The American Association of Immunologists, Inc.

Reporter Gene Insertions Reveal a Strictly B Lymphoid-Specific Expression Pattern of Pax5 in Support of Its B Cell Identity Function1

Martin Fuxa2 and Meinrad Busslinger3

Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria

The transcription factor Pax5 is essential for B cell commitment and development. Although the detailed Pax5 expression pattern within the hemopoietic system is still largely unknown, we previously reported that Pax5 is monoallelically transcribed in pro-B and mature B cells. In this study, we have investigated the expression of Pax5 at single-cell resolution by inserting a GFP or human Cd2 indicator gene under the translational control of an internal ribosomal entry sequence into the 3' untranslated region of Pax5. These insertions were noninvasive, as B cell development was normal in Pax5ihCd2/ihCd2 and Pax5iGFP/iGFP mice. Transheterozygous Pax5ihCd2/iGFP mice coexpressed GFP and human CD2 at similar levels from pro-B to mature B cells, thus demonstrating biallelic expression of Pax5 at all stages of B cell development. No reporter gene expression could be detected in plasma cells and non-B cells of the hemopoietic system. Moreover, the vast majority of common lymphoid progenitors and pre-pro-B cells in the bone marrow of Pax5iGFP/iGFP mice did not yet express GFP, indicating that Pax5 expression is fully switched on only during the transition from uncommitted pre-pro-B cells to committed pro-B cells. Hence, the transcriptional initiation and B cell-specific expression of Pax5 is entirely consistent with its B cell lineage commitment function.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by Boehringer Ingelheim and the Austrian Industrial Research Promotion Fund.

2 Current address: Department of Immunology and Molecular Pathology, University College London, 46 Cleveland Street, London W1T 4JF, U.K.

3 Address correspondence and reprint requests to Dr. Meinrad Busslinger, Research Institute of Molecular Pathology, Vienna Biocenter, Dr. Bohr-Gasse 7, A-1030 Vienna, Austria. E-mail address: busslinger{at}imp.ac.at

4 Abbreviations used in this paper: MPP, multipotent progenitor; CLP, common lymphoid progenitor; IRES, internal ribosomal entry site; DN, double negative; LSK, LinSca1highc-Kithigh progenitor.




This article has been cited by other articles:


Home page
BloodHome page
R. Mansson, S. Zandi, K. Anderson, I.-L. Martensson, S. E. W. Jacobsen, D. Bryder, and M. Sigvardsson
B-lineage commitment prior to surface expression of B220 and CD19 on hematopoietic progenitor cells
Blood, August 15, 2008; 112(4): 1048 - 1055.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.